Key facts
- Notable investors include Delta Capital, Meridian Capital China, Qichen Capital Holdings (Zhuhai).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Yunlian Shikang
- ·The full record, as it builds
Funding rounds
No funding rounds for Yunlian Shikang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yunlian Shikang
Developer of an internet platform for the digital pharmaceutical industry designed to enhance collaboration, streamline distribution, and safeguard public health. The company offers cloud-based warehousing, intelligent logistics, and integrated data services, enabling pharmaceutical enterprises to optimize operations, improve marketing efficiency, and deliver greater value to healthcare providers and consumers.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2021
- Website
- yun-sk.com/
- Ownership
- Privately Held (backing)
Yunlian Shikang doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yunlian Shikang shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yunlian Shikang in its N-PORT filings yet. We sweep new filings monthly.